FANCD2 and breast carcinoma: Although Lewis et al. (2005) first reported that there was no evidence regarding the fact that highly penetrant exonic or splice site mutations in FANCD2 contributed to FBCs, an article published during the next year predicted that mutations in FANCD2 were associated with an increased risk of sporadic breast cancer (Barroso et al., 2006).